Anne Fletcher is the head of the Stromal Immunology Laboratory at the Monash Biomedicine Discovery Institute. The laboratory specialises in human fibroblast cross-talk and differentiation within tumour and lymph node microenvironments, with a focus on developing new drugs that target immune-suppressing fibroblasts. Anne completed her PhD at Monash University, before undertaking a CJ Martin Fellowship at Dana-Farber Cancer Institute / Harvard Medical School, followed by a Birmingham Fellowship at the University of Birmingham (UK). In 2018, Anne returned to Monash, co-founded the Stromal Immunology Network of Australia and New Zealand, and is chairing an upcoming Keystone meeting, "Stromal Immunology in Health and Disease" (February 2026, Banff).